Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and aprotinin for blood loss reduction in pediatric craniosynostosis surgery
IRCT20200705048023N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid and aprotinin in Craniosynostosis (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Intraoperative blood loss, Postoperative blood loss and 2 more. Started Jul 2020; status: completed.
02
Drugs
tranexamic acidaprotinin
03
Conditions
Craniosynostosis
Beyond the preview
Go deeper on IRCT20200705048023N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200705048023N1.